Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report
In Vivo · 2024
DOI: 10.21873/invivo.13592 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, 2024. Verfasst von Masatoshi Nakashima und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Amakusa Medical Center, Kumamoto, Japan. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Adenomatous Polyps. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: The long-term use of proton pump inhibitors (PPIs) has been reported to be strongly associated with the development of fundic gland polyps (FGPs). Conversely, a few cases of gastric hyperplastic polyps (GHPs) associated with PPI use have been reported. We experienced a case of PPI-associated multiple GHPs with uncontrollable bleeding. CASE REPORT: A 64 year old man with a history of rheumatoid arthritis presented to the hospital with complaints of vertigo and black stools. Blood tests revealed anemia and hypoproteinemia. Esophagogastroduodenoscopy (EGD) showed blood and black residue accumulated in the stomach. The source of the bleeding was multiple hyperplastic polyps. Bleeding could be stopped even with fasting, and total blood transfusions amounted to 28 units of RBCs were required in 18 days. After the cessation of PPI, EGD showed that the polyps had almost disappeared. Pathological diagnosis of resected polyp was hyperplastic polyp, which was characterized by capillary hyperplasia and edema. Gastrin receptors were over-expressed in the foveolar epithelium and not in the capillaries. Methotrexate (MTX)-induced portal hypertensive gastroenteropathy was revealed during follow-up. We consider that the effect of portal hypertension may have caused the capillary hyperplasia. CONCLUSION: Although PPI-related polyps are usually fundic gland polyps and do not cause life-threatening adverse events, we experienced PPI-related GHPs in which hemostasis was difficult to control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Amakusa Medical Center, Kumamoto, Japan.
- Department of Gastroenterology and Hepatology, Kumamoto University, Kumamoto, Japan.
- Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; ycomo@kumamoto-u.ac.jp.
- Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
- Department of Endoscopy, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Zitieren
APA
Nakashima, M., Naoe, H., Komohara, Y., Waki, K., Miyamoto, H., Sakai, Y., Kojima, T., Kanemitsu, T., Yao, K., & Tanaka, Y. (2024). Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report. In Vivo. https://doi.org/10.21873/invivo.13592
Vancouver
Nakashima M, Naoe H, Komohara Y, Waki K, Miyamoto H, Sakai Y, et al. Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report. In Vivo. 2024. doi:10.21873/invivo.13592
BibTeX
@article{Nakashima2024,
author = {Nakashima, Masatoshi and Naoe, Hideaki and Komohara, Yoshihiro and Waki, Kotaro and Miyamoto, Hideaki and Sakai, Yoshinari and Kojima, Toshiki and Kanemitsu, Takao and Yao, Kenshi and Tanaka, Yasuhito},
title = {Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13592}
}
EUVIMED